Autor: "Wetzke, M." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease.
Autorzy:: Griese M; Dr. von Hauner Children´s Hospital, University of Munich, German Center for Lung Research (DZL), Lindwurmstraße 4, 80337, Munich, Germany. .
Kappler M; Dr. von Hauner Children´s Hospital, University of Munich, German Center for Lung Research (DZL), Lindwurmstraße 4, 80337, Munich, Germany.
Stehling F; Uniklinikum Essen Pädiatrische Pneumologie, Kinderheilkunde III, Hufelandstr. 55, 45122, Essen, Germany.
Schulze J; Universitätsklinikum Frankfurt Klinik für Kinder- und Jugendmedizin, Pneumologie, Allergologie and Mukoviszidose, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
Baden W; Universitätsklinik für Kinder- und Jugendmedizin Tübingen, Hoppe-Seyler-Str. 1, 72076, Tübingen, Germany.
Koerner-Rettberg C; Universitätsklinik für Kinder- und Jugendmedizin im St. Josef-Hospital Bochum, Alexandrinenstraße 5, 44791, Bochum, Germany.
Carlens J; Department of Paediatric Pneumonology, Allergology and Neonatology, Hannover Medical School, German Center for Lung Research (DZL), Hannover, Germany.
Prenzel F; Klinik und Poliklinik für Kinder- und Jugendmedizin der Universität Leipzig, Liebigstraße 20a, Haus 6, 04103, Leipzig, Germany.
Nährlich L; Department of Pediatrics, Justus-Liebig-University Giessen, German Center for Lung Research, Universities of Giessen and Marburg Lung Center (UGMLC), Giessen, Germany.
Thalmeier A; Pharmacy, University Hospital of Munich, Munich, Germany.
Sebah D; Dr. von Hauner Children´s Hospital, University of Munich, German Center for Lung Research (DZL), Lindwurmstraße 4, 80337, Munich, Germany.
Kronfeld K; IZKS, Interdisciplinary Center for Clinical Trials, University Medical Center Mainz, Mainz, Germany.
Rock H; Central Information Office GmbH, Fronhausen, Bellnhausen, Germany.
Ruckes C; IZKS, Interdisciplinary Center for Clinical Trials, University Medical Center Mainz, Mainz, Germany.
Wetzke M; Department of Paediatric Pneumonology, Allergology and Neonatology, Hannover Medical School, German Center for Lung Research (DZL), Hannover, Germany.
Seidl E; Dr. von Hauner Children´s Hospital, University of Munich, German Center for Lung Research (DZL), Lindwurmstraße 4, 80337, Munich, Germany.
Schwerk N; Department of Paediatric Pneumonology, Allergology and Neonatology, Hannover Medical School, German Center for Lung Research (DZL), Hannover, Germany.; Pokaż więcej
Corporate Authors:: HCQ-study group
Źródło:: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2022 Jul 23; Vol. 17 (1), pp. 289. Date of Electronic Publication: 2022 Jul 23.
Typ publikacji:: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: COVID-19*
Lung Diseases, Interstitial*/drug therapy
Child ; Double-Blind Method ; Humans ; Hydroxychloroquine/adverse effects ; Hydroxychloroquine/therapeutic use ; Prospective Studies ; Quality of Life ; SARS-CoV-2 ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial.
Autorzy:: Griese M; Department of Pediatrics, Dr. von Hauner Children´s Hospital, University Hospital, LMU Munich, German Center for Lung Research (DZL), Lindwurmstraße 4, 80337, Munich, Germany. .
Köhler M; Department of Pediatrics, Dr. von Hauner Children´s Hospital, University Hospital, LMU Munich, German Center for Lung Research (DZL), Lindwurmstraße 4, 80337, Munich, Germany.
Witt S; Department of Pediatrics, Dr. von Hauner Children´s Hospital, University Hospital, LMU Munich, German Center for Lung Research (DZL), Lindwurmstraße 4, 80337, Munich, Germany.
Sebah D; Department of Pediatrics, Dr. von Hauner Children´s Hospital, University Hospital, LMU Munich, German Center for Lung Research (DZL), Lindwurmstraße 4, 80337, Munich, Germany.
Kappler M; Department of Pediatrics, Dr. von Hauner Children´s Hospital, University Hospital, LMU Munich, German Center for Lung Research (DZL), Lindwurmstraße 4, 80337, Munich, Germany.
Wetzke M; Department of Pneumonology, Medical School Hannover, Hannover, Germany.
Schwerk N; Department of Pneumonology, Medical School Hannover, Hannover, Germany.
Emiralioglu N; Department of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Kiper N; Department of Pediatric Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Kronfeld K; IZKS, Interdisciplinary Center for Clinical Trials, University Medical Center Mainz, Mainz, Germany.
Ruckes C; IZKS, Interdisciplinary Center for Clinical Trials, University Medical Center Mainz, Mainz, Germany.
Rock H; Department of Neurology, University of Marburg, Central Information Office, Marburg, Germany.
Anthony G; Department of Neurology, University of Marburg, Central Information Office, Marburg, Germany.
Seidl E; Department of Pediatrics, Dr. von Hauner Children´s Hospital, University Hospital, LMU Munich, German Center for Lung Research (DZL), Lindwurmstraße 4, 80337, Munich, Germany.; Pokaż więcej
Źródło:: Trials [Trials] 2020 Apr 03; Vol. 21 (1), pp. 307. Date of Electronic Publication: 2020 Apr 03.
Typ publikacji:: Clinical Trial Protocol; Journal Article
MeSH Terms:: Hydroxychloroquine/*administration & dosage
Lung Diseases, Interstitial/*drug therapy
Child ; Cross-Over Studies ; Double-Blind Method ; Humans ; Hydroxychloroquine/adverse effects ; Internationality ; Multicenter Studies as Topic ; Prospective Studies ; Randomized Controlled Trials as Topic ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Wetzke, M."" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Publikacja

Język